Concepedia

Yunhong Lu

YL

7

Publications

1.1K

Citations

7

H-Index

2018

Active since

Affiliations

Tianjin Medical University(Current)

Tianjin Infectious Diseases Hospital

Yunhong Lu is an author at Tianjin Medical University specializing in molecular physiology, metabolic signaling, and cell signaling.

Top concepts

Publications per year

2018–2020

7

Publications

7

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

Chenguang Li, Jie Zhang, Mei Xue et al. · Cardiovascular Diabetology · 2019 · 560 citations · Full text

Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease

Mei Xue, Ying Cheng, Fei Han et al. · International Journal of Biological Sciences · 2018 · 112 citations · Full text

Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice

Yunhong Lu, Yunpeng Chang, Ting Li et al. · International Journal of Biological Sciences · 2020 · 111 citations · Full text

Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice

Mei Xue, Ting Li, Yue Wang et al. · Clinical Science · 2019 · 99 citations · Full text

Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes

Ying Cheng, Xiaochen Yu, Jie Zhang et al. · Diabetologia · 2019 · 86 citations · Full text

Rows per page

1–5 of 7